Erik Vollebregt and Mathias Klümper describe a process-oriented and IT-driven business compliance approach that can help pharmaceutical companies avoid contravening fraud and abuse rules in the European Union and the US.
Business compliance is becoming an increasingly important requirement for the pharmaceutical industry...
Please login to read the full article.
